Beijing Polypeptide Biotech Unveils Redesigned Global Website to Advance Peptide CDMO Digitalization
Beijing Polypeptide Biotech Unveils Redesigned Global Website to Enhance Peptide CDMO Digital Services
Subhead: Integrated platform for custom peptide synthesis, GMP peptide drug intermediates, and academic research peptides serving biopharma companies and research institutes worldwide
BEIJING, July 30, 2026 — Beijing Polypeptide Biotech, a leading China-based technology-focused peptide drug R&D and manufacturing enterprise with over 20 years of industry experience, announces the full launch of its upgraded official website:https://www.peptide-bio.com/.
The newly redesigned portal reimagines our full-spectrum peptide service ecosystem, spanning custom research peptides, catalog supplies, cGMP-grade pharmaceutical intermediates, and non-natural amino acid synthesis. Built for global pharma companies, biotech startups, universities, and research labs, the new site delivers streamlined information access, faster inquiry submission, and seamless end-to-end technical communication.
With a team of over 100 professional technicians, Beijing Polypeptide Biotech has overcome technical challenges in synthesizing peptides longer than 180 amino acids, enabling scalable production from milligram to kilogram quantities. Our 3,000 sqm standardized cGMP facility meets ICH Q7 guidelines, providing end-to-end services—from lab-scale R&D customization to compliant commercial manufacturing—for oncology and diabetes peptide therapeutics, antimicrobial peptides, hormonal peptides, and neuropeptides.
The website overhaul addresses surging global demand for peptide drug development and the company’s growing international client base. Key upgrades include:
Streamlined service classification
Four core business modules are displayed independently, highlighting complex modification, fluorescence labeling, PEG conjugation, and heterocyclic building block customization to help clients quickly find solutions that match their research stage.
Transparent quality and delivery highlights
A dedicated compliance section highlights full-process testing systems, strict NDA confidentiality agreements, and fast delivery cycles: standard custom peptides shipped within 2–3 weeks, small research orders fulfilled in as little as 1 week.
One-click service channels
Three key entry points on the homepage: Request a Quote, Project Collaboration, and Technical Consulting. Submit peptide sequences and production scales for custom quotes, consult PhD-level experts on synthesis and modification challenges, or partner with dedicated project managers on joint R&D and GMP manufacturing projects.
Multi-terminal and bilingual optimization
Fully responsive across desktop and mobile devices. Synchronized Chinese and English content, updated corporate profile, technical whitepapers, and global cooperation case studies showcasing the company's strength as an international peptide CDMO.
"Our new website serves as a critical digital bridge to our global partners," the company stated. "This upgrade goes beyond visual improvements; we have redesigned our online service workflow to make our long-chain peptide synthesis and cGMP manufacturing capabilities more accessible worldwide. We remain committed to delivering reliable, high-quality integrated peptide solutions, positioning ourselves as the most trusted partner for global peptide innovation."
Moving forward, Beijing Polypeptide Biotech will regularly publish technical articles, drug development case studies, and downloadable process documents on the new site. We will also launch an online sample request feature to further enhance our digital service ecosystem and accelerate the translation of peptide research into commercial drugs.
About Beijing Polypeptide Biotech
Beijing Polypeptide Biotech is a U.S.-focused, technology-driven Chinese leader in peptide R&D and manufacturing with 20+ years of expertise. The company offers custom peptide synthesis, peptide drug intermediate production, and research-grade peptide services, featuring proprietary technology for peptides exceeding 180 amino acids and scalable mg-to-kg production capacity. Backed by an ICH Q7-aligned-compliant cGMP facility and comprehensive quality inspection and IP protection systems, Beijing Polypeptide Biotech delivers end-to-end peptide solutions—from R&D through clinical development to commercialization—for global biopharma companies and academic institutions.
Contact: +86-18519923863
Website:https://www.peptide-bio.com/